[Aortic valve disease - Interventional aortic valve replacement in asymptomatic patients and the use of artificial intelligence].

Aortic valve diseases are among the most common structural heart diseases in adults. Aortic stenosis (AS), in particular, poses a growing challenge due to demographic trends, as it continues to be underdiagnosed.The current 2025 ESC/EACTS guidelines mark a paradigm shift: for the first time, early intervention is recommended for selected asymptomatic patients. At the same time, various AI tools support early patient screening.Also new, with a Class IIb recommendation, is that TAVI may be considered for patients with a bicuspid aortic valve and increased surgical risk, provided the anatomy is suitable.In addition to that the age limit for TAVI implantation has been lowered to 70 years for patients with suitable anatomy and a tricuspid aortic valve (Class IA recommendation). Another point is that concerning the choice between SAVR and TAVI the importance of the interdisciplinary heart team, taking into account anatomy, comorbidities, and lifestyle considerations was highlighted.Patients with severe aortic valve stenosis should be referred by their primary care cardiologist to a cardiac center so that an interdisciplinary cardiac team can determine the best possible treatment option for the patient.Concerning screening of patients with valvular heart disease artificial intelligence is playing an increasingly important role. Tools such as the digital stethoscope and ECG-based screening help improve patient screening.